Hamilton Thomas Edward Insider Trading Activity

Average Profitability
4.66%
Insider Buys Quantity
5
Insider Buys Sum
$3.76M
Insider Sells Quantity
1
Insider Sells Sum
$1.47M

Insider Activity of Hamilton Thomas Edward

According to the SEC Form 4 filings, Hamilton Thomas Edward, being in a position of

  1. director at Larimar Therapeutics, Inc.,
    оver the last 12 months, has bought 150000 shares for $666,890, and sold 0 shares,
    over all time since 2021-06-30, has bought 581378 shares for $2.66M, and sold 0 shares.

Biography of Hamilton Thomas Edward

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$666,8902100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-07-06PurchaseLarimar Therapeutics, Inc.
LRMR
director
50,000
0.0593%
$3.34$166,890+16.11%
2026-02-27PurchaseLarimar Therapeutics, Inc.
LRMR
director
100,000
0.11%
$5.00$500,000-27.12%
2024-02-16PurchaseLarimar Therapeutics, Inc.
LRMR
director
57,208
0.0891%
$8.74$499,998-41.94%
2022-09-16PurchaseLarimar Therapeutics, Inc.
LRMR
director
317,460
1.4059%
$3.15$999,999+21.72%
2021-06-30PurchaseLarimar Therapeutics, Inc.
LRMR
director
56,710
0.2763%
$8.75$496,213-2.39%
2021-05-03SaleAnnaly Capital Management, Inc.
NLY
director
160,000
0.0114%
$9.18$1.47M-3.85%
2020-05-15PurchaseAnnaly Capital Management, Inc.
NLY
director
200,000
0.0144%
$5.96$1.19M+38.79%
2019-05-17PurchaseAnnaly Capital Management, Inc.
NLY
director
60,000
0.0042%
$9.47$568,200-0.07%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.